Osteoarthritis
From the Journals
Bisphosphonates may have limited ‘protective’ effect against knee OA progression
Women who used bisphosphonates were half as likely as those who did not to experience radiographic progression at 2-year follow up.
Feature
Move over supplements, here come medical foods
When it comes to medical foods, the FDA has often looked the other way because the ingredients may already have been proven safe and the danger to...
Guidelines
EULAR gives pointers on intra-articular injection best practices
A task force based the recommendations on a systematic literature review and two surveys of health professionals and patients to help form expert...
Conference Coverage
Tramadol mortality risk in osteoarthritis could outweigh benefits
Higher all-cause mortality, cardiovascular disease, venous thromboembolism, and hip fracture were seen versus NSAIDs in a large, population-based...
From the Journals
New ‘atlas’ maps links between mental disorders, physical illnesses
“We found that women with anxiety disorders have a 50% increased risk of developing a heart condition or stroke,” said Dr. John McGrath.
Commentary
Advice on treating rheumatic diseases from a COVID-19 epicenter
Hospital for Special Surgery rheumatologists discuss their approach to caring for patients with rheumatic diseases within their practice during...
Guidelines
ACR gives guidance on rheumatic disease management during pandemic
When COVID-19 is suspected, rheumatic disease patients may continue their hydroxychloroquine but other rheumatic disease treatments may need to be...
Conference Coverage
Implantable stimulator shows promise for chronic knee pain
A small, five-patient case series shows pain intensity had dropped substantially 6 months after implantation.
Conference Coverage
Effective osteoarthritis therapy remains elusive
MAUI, HAWAII – ”The question is, have we really moved the needle in this disease in the last 30 years? The answer is I’m not so sure we have.” –...
Conference Coverage
Joint replacement: What’s new in 2020
MAUI, HAWAII – “Congratulations! You’ve eradicated rheumatoid arthritis from my practice,” said orthopedic surgeon Dr. William Bugbee.
News from the FDA/CDC
Prescription osteoarthritis relief gets OTC approval
The diclofenac sodium topical gel previously known as Voltaren Gel 1% will now be sold over the counter as Voltaren Arthritis Pain.